tirzepatide new england journal of medicine Dosage for Weight Loss A 3-year study of tirzepatide

This guide will give you simple, clear answers

Your provider uses this to determine whether you have diabetes or prediabetes (which may influence medication choice), establish a baseline for monitoring blood sugar improvements during treatment, and determine whether diabetes-specific GLP-1 dosing is appropriate

Furthermore, after 52 weeks of treatment, the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS) improved significantly among participants in the tirzepatide arm compared with those in the placebo arm (between-group difference = 6.9 [95% CI 3.310.6]

(Landmark Ed.) 14 , 36413672 (2009)